Government of CanadaPublic Health Agency of Canada / Agency de la santé publique du Canada
   
Skip all navigation -accesskey z Skip to sidemenu -accesskey x Skip to main menu -accesskey m  
Français Contact Us Help Search Canada Site
PHAC Home Centres Publications Guidelines A-Z Index
Child Health Adult Health Seniors HealthSurveillance Health Canada
   
    Public Health Agency of Canada (PHAC)
Canada Communicable Disease Report

[Table of Contents]

 

 

Volume: 23S7 - November 1997

CONTROLLING ANTIMICROBIAL RESISTANCE
An Integrated Action Plan for Canadians

REFERENCES

  1. Panlilio AL, Culver DG, Gaynes RP et al. Methicillin-resistant Staphylococcus aureus in US hospitals 1975-1991. Infect Control Hosp Epidemiol 1992;13:582-86.

  2. Voss A, Milatovic D, Wallrauch-Schwarz C et al. Methicillin-resistant Staphylococcus aureus in Europe. Eur J Clin Microbiol Infect Dis 1994;13:50-5.

  3. Centers for Disease Control and Prevention. Reduced susceptibility of Staphylococcus aureus to vancomycin - Japan, 1996. MMWR 1997;46:624-26.

  4. Low DE, Garcia M, Callery S et al. Methicillin-resistant Staphylococcus aureus - Ontario. CDWR 1981;7: 249-50.

  5. Vortel JJ, Bell A, Farley JD et al. Methicillin-resistant Staphylococcus aureus (MRSA) in a British Columbia hospital - 1990. CDWR 1991;17:71-2.

  6. Boyd N, Gidwani R. Colonization of methicillin-resistant Staphylococcus aureus in southwestern Ontario. CDWR 1991;17:72-3.

  7. Simor AE, Augustin A, Ng J et al. Control of MRSA in a long-term care facility. Infect Control Hosp Epidemiol 1994;15:69-70.

  8. The Canadian Nosocomial Infection Surveillance Program: Results of the first 18 months of surveillance for methicillin-resistant Staphylococcus aureus in Canadian hospitals. CCDR 1997;23:41-6.

  9. Moreno F, Crisp C, Jorgensen JH et al. Methicillin-resistant Staphylococcus aureus as a community organism. Clin Infect Dis 1995;21:1308-12.

  10. Centers for Disease Control and Prevention. Nosocomial enterococci resistant to vancomycin: United States, 1989-93. MMWR 1993;42:597-99.

  11. Conly J, Ofner-Agostini M, Paton S et al. The emerging epidemiology of VRE in Canada: results of the Canadian Nosocomial Infection Surveillance Program (CNISP) Passive Reporting Network (PRN). Abstract presented at the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Sept 28-Oct 1, 1997.

  12. Jette L, Ringuette L. Streptococcus pneumoniae with reduced susceptibility to penicillin G - Quebec. CCDR 1994;20:69-73.

  13. Loo VG, Lavellee J, McAlear D et al. The in-vitro susceptibilities of 326 Streptococcus pneumoniae isolates to nine antimicrobial agents including penicillin and newer quinolones. J Antimicrob Chemother 1994;33: 641-5.

  14. Simor AE, Rachlis A, Louie L et al. Emergence of penicillin-resistant Streptococcus pneumoniae in southern Ontario, 1993-94. Can J Infect Dis 1995;6:157-60.

  15. Simor AE, Louie M. The Canadian Bacterial Surveillance Network, Low DE. Canadian national survey of prevalence of antimicrobial resistance among clinical isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother 1996;40:2190-93.

  16. Matsumura SO, Trpeski L, Pong-Porter S, Comette M, The Canadian Bacterial Surveillance Network, De Azavedo JC, McGeer A, Low DE. Cross Canada surveillance of drug-resistant Streptococcus pneumoniae (DRSP) from 1988 to 1966. Abstract presented at the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Sept 28-Oct 1, 1997.

  17. McGowan JE. Antimicrobial resistance in hospital organisms and its relation to antibiotic use. Rev Infect Dis 1983;5:1033-48.

  18. Baquero F, Martinez-Beltran J, Loza E. A review of antibiotic resistance patterns of Streptococcus pneumoniae in Europe. J Antimicrob Chemother 1991;28(suppl C):31-8.

  19. Redetsky MS, Istre GR, Johansen TL et al. Multiply resistant pneumococcus causing meningitis: its epidemiology within a day care centre. Lancet 1981;ii:771-73.

  20. Hamm RM, Hicks RJ, Bemben DA. Antibiotics and respiratory infections: are patients more satisfied when expectations are met? J Fam Pract 1996;43:56-62.

  21. Langley GJ, Nolan KM, Nolan TW. The foundation of improvement. Quality Progress 1994; June:81-6.

  22. Prochaska J, Velicer WF, Diclemente CC et al. Measuring processes of change: applications to the cessation of smoking. J Cons Clin Psychol 1988;56:520-8.

  23. Hayward RSA, Guyatt GH, Moore KA et al. Canadian physicians' attitudes about and preferences regarding clinical practice guidelines. Can Med Assoc J 1997;156:1715-23.

 

[Previous] [Table of Contents] [Next]
Last Updated: 2002-11-08 Top
Important Notices